Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

Hideyuki Imagawa,1 Saurabh P Nagar,2 William Montgomery,3 Tomomi Nakamura,1 Masayo Sato,1 Keith L Davis2 1Medical Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan; 2RTI Health Solutions, Research Triangle Park, NC, USA; 3Global Patient Outcomes and Real World Evidence, Eli Lilly Australia,...

Cijeli opis

Bibliografski detalji
Glavni autori: Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL
Format: Članak
Jezik:English
Izdano: Dove Medical Press 2018-02-01
Serija:Neuropsychiatric Disease and Treatment
Teme:
ADHD
atomoxetine
treatment patterns
Japan
Online pristup:https://www.dovepress.com/treatment-patterns-health-care-resource-utilization-and-costs-in-japan-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/treatment-patterns-health-care-resource-utilization-and-costs-in-japan-peer-reviewed-article-NDT

Slični predmeti